Tiny radioactive tracer reveals Drug's journey in 5 men
NCT ID NCT06309394
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed Phase 1 study enrolled just 5 healthy men aged 35–55 to see how a single oral dose of the experimental drug INCB099280 (with a tiny radioactive label) is absorbed, broken down, and eliminated. Researchers measured radioactivity in urine and feces and checked drug levels in blood. The goal was purely to understand the drug's path through the body, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INCB099280 (a drug being tested, given as a single oral dose with a radioactive tracer)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quotient Sciences Ltd
Nottingham, NG11 6JS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over movement: can imagining exercise boost balance and brainpower?
- Can a cancer drug be tailored for japanese patients? a new trial seeks answers
- Which pill works best? a trial puts elecoglipron formulations to the test
- Vitamin c may shield postmenopausal hearts without hormones
- Inhaled experimental drug targets tough lung infections
- Meal timing and stomach acid drugs may change how this experimental drug works